Elevated Admission Cardiac Troponin I Predicts Adverse Outcomes of Acute Type B Aortic Dissection after Endovascular Treatment

Elevated Admission Cardiac Troponin I Predicts Adverse Outcomes of Acute Type B Aortic Dissection after Endovascular Treatment

BackgroundThere is a lack of evidence about the predictive role of serum cardiac troponin I (cTnI) on the long-term adverse outcomes of acute type B aortic dissection (aTBAD) patients after thoracic endovascular aortic repair (TEVAR). In this study, we identified whether cTnI was an independent risk...

Full description

Bibliographic Details
Main Authors: Kaiwen Zhao, Hongqiao Zhu, Lei Zhang, Junjun Liu, Yifei Pei, Jian Zhou, Zaiping Jing
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Surgery
Subjects:
acute type B aortic dissection
cardiac troponin I
thoracic endovascular aortic repair
aortic-related adverse events
risk factors
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.789954/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2022.789954/full

Similar Items